HDAC inhibitors suppress protein poly(ADP-ribosyl)ation and DNA repair protein levels and phosphorylation status in hematologic cancer cells: implications for their use in combinat...

por Valdez, Benigno C., Nieto, Yago, Yuan, Bin, Murray, David, Andersson, Borje S.
Publicado 2022

Reprogramming T cell differentiation and exhaustion in CAR-T cell therapy

por Bulliard, Yannick, Andersson, Borje S., Baysal, Mehmet A., Damiano, Jason, Tsimberidou, Apostolia M.
Publicado 2023

ABT199/venetoclax potentiates the cytotoxicity of alkylating agents and fludarabine in acute myeloid leukemia cells

por Valdez, Benigno C., Murray, David, Yuan, Bin, Nieto, Yago, Popat, Uday, Andersson, Borje S.
Publicado 2022

Combination of a hypomethylating agent and inhibitors of PARP and HDAC traps PARP1 and DNMT1 to chromatin, acetylates DNA repair proteins, down-regulates NuRD and induces apoptosis...

por Valdez, Benigno C., Li, Yang, Murray, David, Liu, Yan, Nieto, Yago, Champlin, Richard E., Andersson, Borje S.
Publicado 2017

T-cell receptor-based therapy: an innovative therapeutic approach for solid tumors

por Tsimberidou, Apostolia-Maria, Van Morris, Karlyle, Vo, Henry Hiep, Eck, Stephen, Lin, Yu-Feng, Rivas, Jorge Mauricio, Andersson, Borje S.
Publicado 2021

Differential effects of histone deacetylase inhibitors on cellular drug transporters and their implications for using epigenetic modifiers in combination chemotherapy

por Valdez, Benigno C., Li, Yang, Murray, David, Brammer, Jonathan E., Liu, Yan, Hosing, Chitra, Nieto, Yago, Champlin, Richard E., Andersson, Borje S.
Publicado 2016

Steroid-Refractory Acute GVHD: Predictors and Outcomes

por Westin, Jason R., Saliba, Rima M., De Lima, Marcos, Alousi, Amin, Hosing, Chitra, Qazilbash, Muzaffar H., Khouri, Issa F., Shpall, Elizabeth J., Anderlini, Paolo, Rondon, Gabriela, Andersson, Borje S., Champlin, Richard, Couriel, Daniel R.
Publicado 2011

Phase 2 Clinical Trial of High-Dose Gemcitabine/Busulfan/Melphalan for Autologous Stem-Cell Transplantation in Relapsed/Refractory Myeloma: Matched-Pair Comparison with Melphalan

por Nieto, Yago, Valdez, Benigno C, Pingali, Sai R, Bassett, Roland, Delgado, Ruby, Nguyen, John, Shah, Nina, Popat, Uday, Jones, Roy B, Andersson, Borje S, Gulbis, Alison, Ahmed, Sairah, Bashir, Qaiser, Parmar, Simrit, Patel, Krina, Myers, Alan, Rondon, Gabriela, Orlowski, Robert Z, Champlin, Richard, Qazilbash, Muzaffar
Publicado 2017

Third party, umbilical cord blood derived regulatory T-cells for prevention of graft versus host disease in allogeneic hematopoietic stem cell transplantation: feasibility, safety...

por Kellner, Joshua N., Delemarre, Eveline M., Yvon, Eric, Nierkens, Stefan, Boelens, Jaap J., McNiece, Ian, Olson, Amanda, Nieto, Yago, Ciurea, Stefan, Popat, Uday, Ahmed, Sairah, Champlin, Richard, Ramos, Jennifer, Nishimoto, Mitsutaka, Ma, Hongbing, Ke, Zeng, Thall, Peter, Khoury, Joseph D., Negrin, Robert, Andersson, Borje, Parmar, Simrit
Publicado 2018

A myeloablative fractionated busulfan conditioning regimen with post-transplant cyclophosphamide in HLA-matched and haploidentical transplantation: results of a phase II study

por Popat, Uday R., Andersson, Borje S., Bassett, Roland, Kawedia, Jitesh, Valdez, Ben C., Alousi, Amin M., Al-Atrash, Gheath, Bashir, Qaiser, Hosing, Chitra M., Im, Jin S., Kebriaei, Partow, Marin, David, Nieto, Yago, Oran, Betul, Olson, Amanda, Qazilbash, Muzaffar H., Srour, Samer A., Shpall, Elizabeth J., Champlin, Richard E., Mehta, Rohtesh S.
Publicado 2022

A randomized phase III study of pretransplant conditioning for AML/MDS with fludarabine and once daily IV busulfan ± clofarabine in allogeneic stem cell transplantation

por Andersson, Borje S., Thall, Peter F., Ma, Junsheng, Valdez, Benigno C., Bassett, Roland, Chen, Julianne, Ahmed, Sairah, Alousi, Amin, Bashir, Qaiser, Ciurea, Stefan, Gulbis, Alison, Cool, Rita, Kawedia, Jitesh, Hosing, Chitra, Kebriaei, Partow, Kornblau, Steve, Myers, Alan, Oran, Betul, Rezvani, Katayoun, Shah, Nina, Shpall, Elizabeth, Parmar, Simrit, Popat, Uday R., Nieto, Yago, Champlin, Richard E.
Publicado 2022

Fludarabine with pharmacokinetically-guided IV busulfan is superior to fixed-dose delivery in pretransplant conditioning of AML/MDS patients

por Andersson, Borje S., Thall, Peter F., Valdez, Benigno C., Milton, Denái R., Al-Atrash, Gheath, Chen, Julianne, Gulbis, Alison, Chu, Diem, Martinez, Charles, Parmar, Simrit, Popat, Uday, Nieto, Yago, Kebriaei, Partow, Alousi, Amin, de Lima, Marcos, Rondon, Gabriela, Meng, Qing H., Myers, Alan, Kawedia, Jitesh, Worth, Laura L., Fernandez-Vina, Marcelo, Madden, Timothy, Shpall, Elizabeth J., Jones, Roy B., Champlin, Richard E.
Publicado 2016

Myeloablative fractionated busulfan for allogeneic stem cell transplant in older patients or patients with comorbidities

por Popat, Uday R., Pasvolsky, Oren, Bassett Jr., Roland, Mehta, Rohtesh S., Olson, Amanda, Chen, Julianne, Alousi, Amin M., Al-Atrash, Gheath, Bashir, Qaiser, Gulbis, Alison M., Hosing, Chitra M., Im, Jin S., Kebriaei, Partow, Khouri, Issa, Marin, David, Nieto, Yago, Oran, Betul, Saini, Neeraj, Shigle, Terri Lynn, Srour, Samer A., Ramdial, Jeremy L., Rezvani, Katayoun, Qazilbash, Muzaffar H., Andersson, Borje S., Champlin, Richard E., Shpall, Elizabeth J.
Publicado 2023

P1270: MYELOABLATIVE FRACTIONATED BUSULFAN-BASED CONDITIONING REGIMEN IN PATIENTS WITH AML AND MDS: RESULTS OF A RANDOMIZED CLINICAL TRIAL COMPARING 2 FRACTIONATION SCHEDULES

por Popat, Uday R., Lontos, Konstantinos, Bassett, Roland, Kawedia, Jitesh, Valdez, Ben C., Gulbis, Alison, Alousi, Amin M., Al-Atrash, Gheath, Bashir, Qaiser, Hosing, Chitra M., Im, Jin S., Kebriaei, Partow, Khouri, Issa, Marin, David, Mehta, Rohtesh S., Nieto, Yago, Oran, Betul, Olson, Amanda, Qazilbash, Muzaffar H., Ramdial, Jeremy L., Saini, Neeraj, Srour, Samer A., Kadia, Tapan, Daver, Naval, Short, Nicholas, Rezvani, Katayoun, Shpall, Elizabeth J., Champlin, Richard E., Andersson, Borje S.
Publicado 2023

Improved outcomes of high-risk relapsed Hodgkin lymphoma patients after high-dose chemotherapy: a 15-year analysis

por Nieto, Yago, Gruschkus, Stephen, Valdez, Benigno C., Jones, Roy B., Anderlini, Paolo, Hosing, Chitra, Popat, Uday, Qazilbash, Muzaffar, Kebriaei, Partow, Alousi, Amin, Saini, Neeraj, Srour, Samer, Rezvani, Katayoun, Ramdial, Jeremy, Barnett, Melissa, Gulbis, Alison, Shigle, Terri Lynn, Ahmed, Sairah, Iyer, Swaminathan, Lee, Hun, Nair, Ranjit, Parmar, Simrit, Steiner, Raphael, Dabaja, Bouthaina, Pinnix, Chelsea, Gunther, Jillian, Cuglievan, Branko, Mahadeo, Kris, Khazal, Sajad, Chuang, Hubert, Champlin, Richard, Shpall, Elizabeth J., Andersson, Borje S.
Publicado 2021

Hematology oncology practice in the Asia-Pacific APHCON survey results from the 6th international hematologic malignancies conference: bridging the gap 2015, Beijing, China

por Huang, Xiao Jun, Liu, Kaiyan, Ritchie, David, Andersson, Borje, Lu, Jin, Hou, Jian, Burguera, Adolfo de Fuente, Wang, JianXiang, Yeoh, Allen, Yan, Chenhua, Zhou, Daobin, Tan, Daryl, Kim, Dong Wook, Wu, Depei, Shpall, Elizabeth, Kornblau, Stephen, Neelapu, Sattava, Hongeng, Suradej, Li, Jianyong, Hu, Jiong, Zhang, Lian Sheng, Wang, Michael, Malhotra, Pankaj, Jiang, Qian, Qin, Yazhen, Wong, Raymond, Champlin, Richard, Hagemeister, Frederick, Westin, Jason, Iyer, Swaminathan, Mathews, Vikram, Wang, Yu, Hu, Yu, Xiao, Zhijian, Shao, Zonghong, Orlowski, Robert Z., Chim, Chor Sang, Mulligan, Stephen, Sanz, Miguel, Ozawa, Keiya, Parmar, Simrit, Issaragrisil, Surapol
Publicado 2017